DK1395567T3 - 4-(phenylpiperazinylmethyl)-benzamidderivater og deres anvendelse til behandling af smerte, angst eller mavetarmslidelser - Google Patents

4-(phenylpiperazinylmethyl)-benzamidderivater og deres anvendelse til behandling af smerte, angst eller mavetarmslidelser

Info

Publication number: DK1395567T3
Authority: DK; Denmark
Prior art keywords: phenylpiperazinylmethyl; anxiety; pain; treatment; gastrointestinal disorders
Prior art date: 2001-05-18

Application number

DK02733712T

Other languages

English (en)

Inventor

William Brown

Christopher Walpole

Niklas Plobeck

Hudzik Thomas

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-18

Filing date

2002-05-16

Publication date

2009-04-06

2001-05-18 Priority claimed from SE0101772A external-priority patent/SE0101772D0/xx

2001-11-15 Priority claimed from SE0103820A external-priority patent/SE0103820D0/xx

2002-05-16 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2009-04-06 Application granted granted Critical

2009-04-06 Publication of DK1395567T3 publication Critical patent/DK1395567T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Immunology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)
Transplantation (AREA)
Orthopedic Medicine & Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Furan Compounds (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)
Pyridine Compounds (AREA)

DK02733712T 2001-05-18 2002-05-16 4-(phenylpiperazinylmethyl)-benzamidderivater og deres anvendelse til behandling af smerte, angst eller mavetarmslidelser DK1395567T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE0101772A SE0101772D0 (sv)	2001-05-18	2001-05-18	Novel compounds
SE0103820A SE0103820D0 (sv)	2001-11-15	2001-11-15	Novel compounds
PCT/SE2002/000956 WO2002094794A1 (en)	2001-05-18	2002-05-16	4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders

Publications (1)

Publication Number	Publication Date
DK1395567T3 true DK1395567T3 (da)	2009-04-06

Family

ID=26655470

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02733712T DK1395567T3 (da)	2001-05-18	2002-05-16	4-(phenylpiperazinylmethyl)-benzamidderivater og deres anvendelse til behandling af smerte, angst eller mavetarmslidelser

Country Status (32)

Country	Link
US (3)	US7229994B2 (da)
EP (2)	EP2042495A1 (da)
JP (2)	JP4549024B2 (da)
KR (2)	KR100885100B1 (da)
CN (1)	CN1269805C (da)
AR (1)	AR035974A1 (da)
AT (1)	ATE420866T1 (da)
AU (1)	AU2002305994B2 (da)
BG (1)	BG108333A (da)
BR (1)	BR0209678A (da)
CA (1)	CA2446326C (da)
CO (1)	CO5540309A2 (da)
CY (1)	CY1108913T1 (da)
CZ (1)	CZ20033092A3 (da)
DE (1)	DE60230869D1 (da)
DK (1)	DK1395567T3 (da)
EE (1)	EE05243B1 (da)
ES (1)	ES2319876T3 (da)
HK (1)	HK1061237A1 (da)
HU (1)	HUP0401086A3 (da)
IL (2)	IL158631A0 (da)
IS (1)	IS2625B (da)
MX (1)	MXPA03010445A (da)
MY (1)	MY140070A (da)
NO (1)	NO326632B1 (da)
NZ (2)	NZ539828A (da)
PL (1)	PL367142A1 (da)
PT (1)	PT1395567E (da)
RU (1)	RU2297412C2 (da)
SI (1)	SI1395567T1 (da)
SK (1)	SK287555B6 (da)
WO (1)	WO2002094794A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2446326C (en) *	2001-05-18	2010-12-07	Astrazeneca Ab	4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
US7030124B2 (en)	2001-10-29	2006-04-18	Ardent Pharmaceuticals, Inc.	Method of treating depression with delta receptor agonist compounds
SE0203302D0 (sv) *	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203303D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203300D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
KR101255074B1 (ko)	2003-10-01	2013-04-16	아돌로 코포레이션	스피로시클릭 헤테로시클릭 유도체 및 이의 사용 방법
SE0401968D0 (sv) *	2004-08-02	2004-08-02	Astrazeneca Ab	Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
MX2007001240A (es)	2004-08-02	2007-03-23	Astrazeneca Ab	Derivados de diarilmetil-piperazina, preparaciones y usos de las mismas.
EP1856076A1 (en) *	2005-02-28	2007-11-21	AstraZeneca AB	Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
US7598261B2 (en)	2005-03-31	2009-10-06	Adolor Corporation	Spirocyclic heterocyclic derivatives and methods of their use
TWI439452B (zh)	2005-05-13	2014-06-01	Otsuka Pharma Co Ltd	吡咯烷化合物（二）
EP1915355A1 (en) *	2005-08-08	2008-04-30	AstraZeneca AB	Therapeutic agents
US7576207B2 (en)	2006-04-06	2009-08-18	Adolor Corporation	Spirocyclic heterocyclic derivatives and methods of their use
WO2007137417A1 (en) *	2006-05-26	2007-12-06	Neuromed Pharmaceuticals Ltd.	Heterocyclic compounds as calcium channel blockers
WO2008033299A2 (en)	2006-09-12	2008-03-20	Adolor Corporation	Use of n-containing spirocompounds for the enhancement of cognitive function
CA2724955A1 (en) *	2008-05-20	2009-11-26	Astrazeneca Ab	Method of treating anxious major depressive disorder
US20110160184A1 (en)	2008-06-20	2011-06-30	Astrazeneca Ab	Dibenzothiazepine Derivatives and Use Thereof
GB201111704D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Novel compounds
GB201111705D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Compounds and their use
JO3115B1 (ar)	2011-08-22	2017-09-20	Takeda Pharmaceuticals Co	مركبات بيريدازينون واستخدامها كمثبطات daao
GB201209587D0 (en)	2012-05-30	2012-07-11	Takeda Pharmaceutical	Therapeutic compounds
CA2914263C (en)	2013-06-21	2021-05-18	Takeda Pharmaceutical Company Limited	1-sulfonyl piperidine derivatives as modulators of prokineticin receptors
GB201314286D0 (en)	2013-08-08	2013-09-25	Takeda Pharmaceutical	Therapeutic Compounds
GB201318222D0 (en)	2013-10-15	2013-11-27	Takeda Pharmaceutical	Novel compounds
GB201320905D0 (en)	2013-11-27	2014-01-08	Takeda Pharmaceutical	Therapeutic compounds
TW201613864A (en)	2014-02-20	2016-04-16	Takeda Pharmaceutical	Novel compounds
CN104163788A (zh) *	2014-07-07	2014-11-26	湖南华腾制药有限公司	一种吡啶衍生物的制备方法
GB201616839D0 (en)	2016-10-04	2016-11-16	Takeda Pharmaceutical Company Limited	Therapeutic compounds
GB201619514D0 (en)	2016-11-18	2017-01-04	Takeda Pharmaceuticals Co	Novel compounds
JP2021138648A (ja)	2020-03-04	2021-09-16	武田薬品工業株式会社	経口固形製剤
CN113398131B (zh) *	2020-11-05	2022-03-01	东南大学	1-二苯甲基-4-甲基哌嗪类化合物在制备改善肠道菌群紊乱药物中的应用

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH585209A5 (da)	1973-06-29	1977-02-28	Cermol Sa
DE2900810A1 (de)	1979-01-11	1980-07-24	Cassella Ag	Substituierte n-benzhydryl-n'-p- hydroxybenzyl-piperazine und verfahren zu ihrer herstellung
IT1140978B (it)	1980-05-23	1986-10-10	Selvi & C Spa	1-(4-clorobenzidril)-4-(2,3-diidros sipropil)-piperazina, metodi per la sua preparazione e relative composizione farmaceutiche
GB8320701D0 (en)	1983-08-01	1983-09-01	Wellcome Found	Chemotherapeutic agent
IT1196150B (it)	1984-06-19	1988-11-10	Poli Ind Chimica Spa	Derivati di 1-(bis-(4-fluorofenil)metil)-4-(3-fenil-2-propenil)-esaidro-1h-1,4-diazepina ad attivita' calcio antagonista,sua preparazione e composizioni che lo contengono
SE8500573D0 (sv)	1985-02-08	1985-02-08	Ferrosan Ab	Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain
US5028610A (en)	1987-03-18	1991-07-02	Sankyo Company Limited	N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use
US4829065A (en)	1987-04-24	1989-05-09	Syntex Pharmaceuticals, Ltd.	Substituted imidazolyl-alkyl-piperazine and -diazepine derivatives
US4826844A (en)	1987-09-30	1989-05-02	American Home Products Corporation	Substituted 1-(aralkyl-piperazinoalkyl) cycloalkanols
RU2093156C1 (ru)	1989-11-22	1997-10-20	Жансен Фармасетика Н.В.	L-(-)-2-(аминокарбонил)-n-(4-амино-2,6-дихлорфенил-4[5,5-бис(4-фторфенил)пентил]-1-пиперазинацетамид, его фармацевтически приемлемая кислотно-аддитивная соль или гидрат, способ его получения и средство для хранения сердца донора
US5840896A (en)	1989-11-22	1998-11-24	Janssen Pharmaceutica, N.V.	Method of preventing or limiting reperfusion damage
ES2109276T3 (es)	1990-08-29	1998-01-16	Upjohn Co	Derivados de tropolona y composicion farmaceutica de los mismos para prevenir y tratar enfermedades isquemicas.
CZ280532B6 (cs)	1990-10-10	1996-02-14	Schering Corporation	Pyridinové a pyridin-N-oxidové deriváty diaryl-methyl-piperidinů nebo piperazinů, jejich použití a způsob jejich přípravy, farmaceutický prostředek je obsahující
GB9202238D0 (en)	1992-02-03	1992-03-18	Wellcome Found	Compounds
US5681830A (en)	1992-02-03	1997-10-28	Delta Pharmaceuticals, Inc.	Opioid compounds
US5807858A (en)	1996-06-05	1998-09-15	Delta Pharmaceutical, Inc.	Compositions and methods for reducing respiratory depression
US5985880A (en)	1996-06-05	1999-11-16	Delta Pharmaceuticals	Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
US5574159A (en)	1992-02-03	1996-11-12	Delta Pharmaceuticals, Inc.	Opioid compounds and methods for making therefor
FR2696744B1 (fr)	1992-10-12	1994-12-30	Logeais Labor Jacques	Dérivés de 2-pyrrolidone, leur procédé de préparation et leurs applications en thérapeutique.
RU2124511C1 (ru)	1993-05-14	1999-01-10	Фармасьютикал Ко., Лтд	Производные пиперазина
RU2133744C1 (ru)	1993-07-30	1999-07-27	Дельта Фармасьютикалз, Инк.	Пиперазиновые соединения
JP3352184B2 (ja)	1993-11-12	2002-12-03	株式会社アズウェル	ピペラジン不飽和脂肪酸誘導体
IL117149A0 (en)	1995-02-23	1996-06-18	Schering Corp	Muscarinic antagonists
SE9504661D0 (sv)	1995-12-22	1995-12-22	Astra Pharma Inc	New compounds
SE9604786D0 (sv)	1996-12-20	1996-12-20	Astra Pharma Inc	New compounds
TW548271B (en)	1996-12-20	2003-08-21	Astra Pharma Inc	Novel piperidine derivatives having an exocyclic double bond with analgesic effects
AU2009799A (en)	1997-12-24	1999-07-19	Ortho-Mcneil Pharmaceutical, Inc.	4-(aryl(piperidin-4-yl)) aminobenzamides which bind to the delta-opioid receptor
US6011035A (en)	1998-06-30	2000-01-04	Neuromed Technologies Inc.	Calcium channel blockers
SE9904675D0 (sv)	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
SE9904674D0 (sv)	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
SE9904673D0 (sv)	1999-12-20	1999-12-20	Astra Pharma Inc	Novel compounds
SE0001209D0 (sv) *	2000-04-04	2000-04-04	Astrazeneca Canada Inc	Novel compounds
CA2446326C (en)	2001-05-18	2010-12-07	Astrazeneca Ab	4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
SE0101766D0 (sv)	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0101765D0 (sv)	2001-05-18	2001-05-18	Astrazeneca Ab	Novel compounds
SE0103313D0 (sv)	2001-10-03	2001-10-03	Astrazeneca Ab	Novel compounds
US7030124B2 (en) *	2001-10-29	2006-04-18	Ardent Pharmaceuticals, Inc.	Method of treating depression with delta receptor agonist compounds
US8476280B2 (en)	2002-05-09	2013-07-02	Versi Group, Llc	Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
SE0203303D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203300D0 (sv)	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0203302D0 (sv) *	2002-11-07	2002-11-07	Astrazeneca Ab	Novel Compounds
SE0300105D0 (sv)	2003-01-16	2003-01-16	Astrazeneca Ab	Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
SE0400027D0 (sv)	2004-01-09	2004-01-09	Astrazeneca Ab	Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
SE0401968D0 (sv)	2004-08-02	2004-08-02	Astrazeneca Ab	Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
MX2007001240A (es)	2004-08-02	2007-03-23	Astrazeneca Ab	Derivados de diarilmetil-piperazina, preparaciones y usos de las mismas.
EP1856076A1 (en)	2005-02-28	2007-11-21	AstraZeneca AB	Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
CA2724955A1 (en)	2008-05-20	2009-11-26	Astrazeneca Ab	Method of treating anxious major depressive disorder

2002
- 2002-05-16 CA CA2446326A patent/CA2446326C/en not_active Expired - Fee Related
- 2002-05-16 HU HU0401086A patent/HUP0401086A3/hu unknown
- 2002-05-16 KR KR1020037014950A patent/KR100885100B1/ko not_active IP Right Cessation
- 2002-05-16 CZ CZ20033092A patent/CZ20033092A3/cs unknown
- 2002-05-16 CN CNB028141695A patent/CN1269805C/zh not_active Expired - Fee Related
- 2002-05-16 IL IL15863102A patent/IL158631A0/xx unknown
- 2002-05-16 BR BR0209678-1A patent/BR0209678A/pt not_active Withdrawn
- 2002-05-16 NZ NZ539828A patent/NZ539828A/en unknown
- 2002-05-16 MY MYPI20021785A patent/MY140070A/en unknown
- 2002-05-16 AT AT02733712T patent/ATE420866T1/de active
- 2002-05-16 AR ARP020101817A patent/AR035974A1/es active IP Right Grant
- 2002-05-16 EP EP08171062A patent/EP2042495A1/en not_active Withdrawn
- 2002-05-16 RU RU2003131964/04A patent/RU2297412C2/ru not_active IP Right Cessation
- 2002-05-16 PT PT02733712T patent/PT1395567E/pt unknown
- 2002-05-16 WO PCT/SE2002/000956 patent/WO2002094794A1/en active Application Filing
- 2002-05-16 JP JP2002591467A patent/JP4549024B2/ja not_active Expired - Fee Related
- 2002-05-16 EE EEP200300545A patent/EE05243B1/xx not_active IP Right Cessation
- 2002-05-16 EP EP02733712A patent/EP1395567B1/en not_active Expired - Lifetime
- 2002-05-16 NZ NZ529401A patent/NZ529401A/en unknown
- 2002-05-16 DE DE60230869T patent/DE60230869D1/de not_active Expired - Lifetime
- 2002-05-16 DK DK02733712T patent/DK1395567T3/da active
- 2002-05-16 SK SK1398-2003A patent/SK287555B6/sk not_active IP Right Cessation
- 2002-05-16 SI SI200230797T patent/SI1395567T1/sl unknown
- 2002-05-16 ES ES02733712T patent/ES2319876T3/es not_active Expired - Lifetime
- 2002-05-16 US US10/477,642 patent/US7229994B2/en not_active Expired - Fee Related
- 2002-05-16 AU AU2002305994A patent/AU2002305994B2/en not_active Ceased
- 2002-05-16 KR KR1020087026556A patent/KR100915263B1/ko not_active IP Right Cessation
- 2002-05-16 PL PL02367142A patent/PL367142A1/xx unknown
- 2002-05-16 MX MXPA03010445A patent/MXPA03010445A/es active IP Right Grant
2003
- 2003-10-27 IL IL158631A patent/IL158631A/en not_active IP Right Cessation
- 2003-11-07 BG BG108333A patent/BG108333A/bg unknown
- 2003-11-12 CO CO03100169A patent/CO5540309A2/es not_active Application Discontinuation
- 2003-11-13 IS IS7032A patent/IS2625B/is unknown
- 2003-11-17 NO NO20035120A patent/NO326632B1/no not_active IP Right Cessation
2004
- 2004-06-14 HK HK04104288.9A patent/HK1061237A1/xx not_active IP Right Cessation
2007
- 2007-05-03 US US11/743,824 patent/US7915413B2/en not_active Expired - Fee Related
2009
- 2009-03-19 CY CY20091100308T patent/CY1108913T1/el unknown
2010
- 2010-01-08 JP JP2010002450A patent/JP5028500B2/ja not_active Expired - Fee Related
- 2010-10-25 US US12/911,167 patent/US8022074B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7229994B2 (en)	2007-06-12
EP1395567B1 (en)	2009-01-14
ATE420866T1 (de)	2009-01-15
KR20040000471A (ko)	2004-01-03
CY1108913T1 (el)	2014-07-02
JP4549024B2 (ja)	2010-09-22
EE05243B1 (et)	2009-12-15
IL158631A0 (en)	2004-05-12
CN1527820A (zh)	2004-09-08
PT1395567E (pt)	2009-03-26
MXPA03010445A (es)	2004-03-09
CN1269805C (zh)	2006-08-16
NO326632B1 (no)	2009-01-26
KR100885100B1 (ko)	2009-02-20
WO2002094794A1 (en)	2002-11-28
US20070270435A1 (en)	2007-11-22
DE60230869D1 (de)	2009-03-05
CA2446326A1 (en)	2002-11-28
IS2625B (is)	2010-05-15
EP1395567A1 (en)	2004-03-10
AR035974A1 (es)	2004-07-28
HUP0401086A3 (en)	2011-07-28
CZ20033092A3 (cs)	2004-08-18
US20040147526A1 (en)	2004-07-29
KR20080106586A (ko)	2008-12-08
MY140070A (en)	2009-11-30
NZ529401A (en)	2005-09-30
NZ539828A (en)	2007-01-26
RU2003131964A (ru)	2005-05-10
IS7032A (is)	2003-11-13
IL158631A (en)	2010-12-30
BR0209678A (pt)	2004-09-14
EE200300545A (et)	2004-02-16
JP2010132670A (ja)	2010-06-17
SI1395567T1 (sl)	2009-04-30
AU2002305994B2 (en)	2008-06-26
US20110039858A1 (en)	2011-02-17
CA2446326C (en)	2010-12-07
ES2319876T3 (es)	2009-05-14
RU2297412C2 (ru)	2007-04-20
US8022074B2 (en)	2011-09-20
HUP0401086A2 (hu)	2004-08-30
JP5028500B2 (ja)	2012-09-19
KR100915263B1 (ko)	2009-09-03
JP2005508293A (ja)	2005-03-31
SK13982003A3 (sk)	2004-04-06
CO5540309A2 (es)	2005-07-29
SK287555B6 (sk)	2011-01-04
EP2042495A1 (en)	2009-04-01
WO2002094794A8 (en)	2004-04-22
PL367142A1 (en)	2005-02-21
NO20035120D0 (no)	2003-11-17
HK1061237A1 (en)	2004-09-10
BG108333A (bg)	2004-12-30
US7915413B2 (en)	2011-03-29

Publication	Publication Date	Title
DK1395567T3 (da)	2009-04-06	4-(phenylpiperazinylmethyl)-benzamidderivater og deres anvendelse til behandling af smerte, angst eller mavetarmslidelser
DK1392292T3 (da)	2006-05-29	Pyranoindazoler og deres anvendelse til behandling af glaukom
NO20035116D0 (no)	2003-11-17	4-(fenylpiperidin-4-yliden-metyl)-benzamidderivater og deres anvendelse forbehandling av smerte, angst eller gastrointestinale forstyrrelser
IS7203A (is)	2004-03-31	4[píperidín-4-ýliden-(3-karbamólýlfenýl)metýl]bensamíðafleiður og notkun þeirra til að meðhöndla verki, mænuskaða eða maga- og garnasjúkdóma
NO20035115D0 (no)	2003-11-17	4-(fenylpiperidin-4-yliden-metyl)-benzamidderivater og deres anvendelse forbehandling av smerte, angst eller gastrointestinale forstyrrelser
NO20052698D0 (no)	2005-06-06	4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser.
NO20052699D0 (no)	2005-06-06	4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
NO20035117D0 (no)	2003-11-17	4-(fenylpiperidin-4-yliden-metyl)-benzamidderivater og deres anvendelse forbehandling av smerte, angst eller gastrointestinale forstyrrelser
NO20035118D0 (no)	2003-11-17	4-(fenylpiperidin-4-yliden-metyl)-benzamidderivater og deres anvendelse forbehandling av smerte, angst eller gastrointestinale forstyrrelser
NO20035114D0 (no)	2003-11-17	4-(fenyl-(piperidin-4-yl)-amino)-benzamidderivater og deres anvendelse vedbehandling av angst, smerte eller gastrointestinale forstyrrelser
NO20035113D0 (no)	2003-11-17	4-(fenyl-(piperidin-4-yl)-amino)-benzamidderivater og deres anvendelse vedbehandling av angst, smerte eller gastrointestinale forstyrrelser
NO20035112D0 (no)	2003-11-17	4-(fenyl-(piperidin-4-yl)-amino)-benzamidderivater og deres anvendelse vedbehandling av smerte, angst eller gastrointestinale forstyrrelser
NO20035119D0 (no)	2003-11-17	4-(fenyl-(piperidin-4-yl)-amino)-benzamidderivater og deres anvendelse vedbehandling av angst, smerte eller gastrointestinale forstyrrelser